Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.

Abstract:

:The endocannabinoid system (ECS) is now recognised as an important modulator of various central nervous system processes. More recently, an increasing body of evidence has accumulated to suggest antioxidant, anti-inflammatory and neuroprotective roles of ECS. In this review we discuss the role and therapeutic potential of ECS in neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease, multiple sclerosis, Huntington's disease, Tourette's syndrome, brain ischemia and amyotrophic lateral sclerosis (ALS). Elements of the ECS, such as fatty acid amide hydrolase or the cannabinoid receptors are now considered as promising pharmacological targets for some diseases. Although still preliminary, recent reports suggest that modulation of the ECS may constitute a novel approach for the treatment of AD. There are windows of opportunity in conditions caused by acute events such as trauma and ischemia as well in conditions that may involve altered functionality of the target receptors of the ECS, such as in AD. The ECS changes in Parkinson's disease could be compensatory as well as pathogenic of the illness process and needs further understanding and clinical studies are still in the preliminary stage. There is not enough evidence to support use of cannabinoids in treating Huntington's disease, tics and obsessive compulsive behaviour in Tourette's syndrome. Evidence on therapeutic use of cannabinoids in multiple sclerosis and ALS is currently limited. A major challenge for future research is the development of novel compounds with more selectivity for various components of the ECS which could target different neurotoxic pathways and be used in combination therapy.

journal_name

Curr Pharm Des

authors

Velayudhan L,Van Diepen E,Marudkar M,Hands O,Suribhatla S,Prettyman R,Murray J,Baillon S,Bhattacharyya S

doi

10.2174/13816128113199990434

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

2218-30

issue

13

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-11-05-07-2013

journal_volume

20

pub_type

杂志文章,评审
  • Strategies to Avoid TAVI-related Acute Kidney Injury.

    abstract::Acute kidney injury (AKI) is relatively common in patients undergoing transcatheter aortic valve implantation (TAVI) and has been associated with increased mortality and worse outcomes. The administration of iodinated contrast media in an elderly population with increased rates of chronic kidney injury and heart failu...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151208120522

    authors: Kampaktsis PN,Feldman DN,Charitakis K

    更新日期:2016-01-01 00:00:00

  • Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders.

    abstract::The frequency of neuropsychiatric disorders is greater than that of cancer, cardiovascular disease, and diabetes combined, and is growing at a faster rate than any other ailments in the United States or Europe. Despite a considerable need for the development of treatments for central nervous system disorders, pharmace...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160127111453

    authors: Schroeder RA,Wecker L,Philpot RM

    更新日期:2016-01-01 00:00:00

  • The Inflammation Network in the Pathogenesis of Erectile Dysfunction: Attractive Potential Therapeutic Targets.

    abstract:BACKGROUND:Erectile dysfunction (ED) is an evolving health problem in the aging male population. Chronic low-grade inflammation is a critical component of ED pathogenesis and a probable intermediate stage of endothelial dysfunction, especially in metabolic diseases, with the inclusion of obesity, metabolic syndrome, an...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200424161018

    authors: Kaya-Sezginer E,Gur S

    更新日期:2020-01-01 00:00:00

  • Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors.

    abstract::The rapid advancement of computer architectures and development of mathematical algorithms offer a unique opportunity to leverage the simulation of macromolecular systems at physiologically relevant timescales. Herein, we discuss the impact of diverse structure-based and ligand-based molecular modeling techniques in d...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190304123545

    authors: Samanta PN,Kar S,Leszczynski J

    更新日期:2019-01-01 00:00:00

  • Potential cardio-protective agents: A Resveratrol review (2000-2019).

    abstract::With a 2030 projection of 23.6 million deaths per year the prevalence and severity of cardiovascular disease is at an astounding high. Thus, a definitive need for the identification of novel compounds with potential to prevent or treat the disease and associated states. Moreover, there is also an ever-increasing need ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200909125354

    authors: Houacine C,Khan I,Yousaf SS

    更新日期:2020-09-09 00:00:00

  • Receptor binding ligands to image infection.

    abstract::The current gold standard for imaging infection is radiolabeled white blood cells. For reasons of safety, simplicity and cost, it would be desirable to have a receptor-specific ligand that could be used for imaging infection and that would allow a differential diagnosis between sterile and septic inflammatory processe...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208786549416

    authors: Chianelli M,Boerman OC,Malviya G,Galli F,Oyen WJ,Signore A

    更新日期:2008-01-01 00:00:00

  • Molecular recognition explored by a statistical-mechanics theory of liquids.

    abstract::"Molecular recognition" is one of the most important molecular processes for living systems in order to maintain their life, since most of the biological functions are initiated with the process. Understanding of the process is also important for designing a new drug. Firstly, it is important to find a target of a dru...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211796355100

    authors: Phongphanphanee S,Yoshida N,Hirata F

    更新日期:2011-01-01 00:00:00

  • Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.

    abstract::Recent decades mark a great progress in the treatment of HIV infection. What was once a deadly disease is now a chronic infection. However, HIV-infected patients are prone to develop comorbidities, which severely affect their daily functions. For example, a large population of patients develop a variety of neurologica...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160726113001

    authors: Bertrand L,Nair M,Toborek M

    更新日期:2016-01-01 00:00:00

  • Hydrogen Gas as an Exotic Performance-Enhancing Agent: Challenges and Opportunities.

    abstract:BACKGROUND:Hydrogen gas (H2 ) has entered the world of experimental therapeutics approximately four and a half decades ago. Over the years, this simple molecule appears to drive more and more scientific attention perhaps due to a dualism of H2 affirmative features demonstrated in numerous in vitro, animal and human stu...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200922155242

    authors: Ostojic SM

    更新日期:2020-09-22 00:00:00

  • Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?

    abstract::The beneficial effect of antihypertensive treatment on the risk of major vascular events is well established. Several trials comparing older and newer drugs in the treatment of primary hypertension suggested that it is the blood pressure achieved, rather than choice of the drug that determines most of the primary outc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207779313713

    authors: Karagiannis A,Mikhailidis DP,Kakafika AI,Tziomalos K,Athyros VG

    更新日期:2007-01-01 00:00:00

  • Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation.

    abstract::Arterial thromboembolism is a sudden obstruction of arterial blood flow caused by dislodgment of a blood clot from the site of its formation. Atrial fibrillation (AF) is the most common cardiac arrhythmia and a major risk factor for arterial thromboembolism in clinical practice. Most of AF-related arterial thromboembo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210793563400

    authors: Potpara TS,Lip GY

    更新日期:2010-01-01 00:00:00

  • Gene Delivery with Organic Electronic Biomaterials.

    abstract::Gene therapy may be capable of treating a variety of diseases, a prerequisite of which is the successful delivery of polynucleic acids (e.g., DNA, RNA) to a patient's cells. Delivery can be achieved technologically (e.g., using electroporation), using viruses (natural gene delivery vectors) or non-viral vectors (e.g.,...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170710124137

    authors: Clancy KFA,Hardy JG

    更新日期:2017-01-01 00:00:00

  • TNF(alpha) modulation of visceral and spinal sensory processing.

    abstract::The cytokine tumor necrosis factor(alpha) (TNF(alpha)) is associated with a constellation of physiological and behavioral characteristics that follow in response to infection such as fever, fatigue, listlessness, loss of appetite, malaise, and tactile hypersensitivity. These responses are examples of central nervous s...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612053507828

    authors: Hermann GE,Holmes GM,Rogers RC

    更新日期:2005-01-01 00:00:00

  • Early life and oxidative stress in psychiatric disorders: what can we learn from animal models?

    abstract::Schizophrenia is a complex pathology characterized by the occurrence of a variety of symptoms classified as positive, negative and cognitive. Although the exact etiopathogenesis of this disorder has not been unraveled yet, many theories have been endorsed during the last years. Among these, the neurochemical theories ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150105122422

    authors: Mhillaj E,Morgese MG,Trabace L

    更新日期:2015-01-01 00:00:00

  • Method Development in Forensic Toxicology.

    abstract:BACKGROUND:In the field of forensic toxicology, the quality of analytical methods is of great importance to ensure the reliability of results and to avoid unjustified legal consequences. A key to high quality analytical methods is a thorough method development. METHODS:The presented article will provide an overview on...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170622113331

    authors: Peters FT,Wissenbach DK,Busardo FP,Marchei E,Pichini S

    更新日期:2017-01-01 00:00:00

  • BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.

    abstract::Commonly, the angiogenic growth factors signify healing. However, gastrointestinal ulceration is still poorly understood particularly with respect to a general pharmacological/pathophysiological role of various angiogenic growth factors implemented in growth factors wound healing concept. Thereby, we focused on the st...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180712110447

    authors: Seiwerth S,Rucman R,Turkovic B,Sever M,Klicek R,Radic B,Drmic D,Stupnisek M,Misic M,Vuletic LB,Pavlov KH,Barisic I,Kokot A,Japjec M,Blagaic AB,Tvrdeic A,Rokotov DS,Vrcic H,Staresinic M,Sebecic B,Sikiric P

    更新日期:2018-01-01 00:00:00

  • Clinical implications of macrolide therapy in chronic sinopulmonary diseases.

    abstract::Macrolides have broad antibacterial spectrum and proven efficacy in the management of respiratory tract infections. Over the past decade there has been progressive interest in these agents for their potential role as tissue modifying, anti-inflammatory agents. Increasingly, the effect of macrolides on numerous cell ty...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043383304

    authors: Martinez FJ,Simon RH

    更新日期:2004-01-01 00:00:00

  • Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.

    abstract:BACKGROUND:The drug delivery of macromolecules such as proteins and peptides has become an important area of research and represents the fastest expanding share of the market for human medicines. The most common method for delivering macromolecules is parenterally. However parenteral administration of some therapeutic ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161026163201

    authors: Shadab M,Haque S,Sheshala R,Meng LW,Meka VS,Ali J

    更新日期:2017-01-01 00:00:00

  • Caenorhabditis elegans-based model systems for antifungal drug discovery.

    abstract::The substantial morbidity and mortality associated with invasive fungal infections constitute undisputed tokens of their severity. The continued expansion of susceptible population groups (such as immunocompromised individuals, patients undergoing extensive surgery, and those hospitalized with serious underlying disea...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211795703753

    authors: Anastassopoulou CG,Fuchs BB,Mylonakis E

    更新日期:2011-01-01 00:00:00

  • Inhibitors of tryptase for the treatment of mast cell-mediated diseases.

    abstract::Human tryptase is a structurally unique and mast cell specific trypsin-like serine protease. Recent biological and immunological investigations have implicated tryptase as a mediator in the pathology of numerous allergic and inflammatory conditions including rhinitis, conjunctivitis, and most notably asthma. A growing...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Rice KD,Tanaka RD,Katz BA,Numerof RP,Moore WR

    更新日期:1998-10-01 00:00:00

  • Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease.

    abstract:BACKGROUND:A substantial part of literature has been centered on sex differences in the clinical aspects of ischemic heart disease (IHD). Many reports have documented differences in the presentation and risk profile between women and men. Such differences drive sex-related inequalities in the referral and treatment of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160311115344

    authors: Cenko E,Bugiardini R

    更新日期:2016-01-01 00:00:00

  • Monocyte as an Emerging Tool for Targeted Drug Delivery: A Review.

    abstract::Monocytes are leading component of the mononuclear phagocytic system that play a key role in phagocytosis and removal of several kinds of microbes from the body. Monocytes are bone marrow precursor cells that stay in the blood for a few days and migrate towards tissues where they differentiate into macrophages. Monocy...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190102104642

    authors: Sabir F,Farooq RK,Asim Ur Rehman,Ahmed N

    更新日期:2018-01-01 00:00:00

  • Appreciation of medical treatments through confidence intervals.

    abstract::The typical way of judging about either the efficacy of a new treatment or, on the contrary, the damage of a pollutant agent is through a test of hypothesis having its ineffectiveness as null hypothesis. This is the typical operational field of Kolmogorov's statistical framework where wastes of data (for instance non ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207780765891

    authors: Apolloni B,Bassis S,Gaito S,Malchiodi D

    更新日期:2007-01-01 00:00:00

  • Inflammatory cytokines, growth factors, and depression.

    abstract::There is a plausible role for cytokines, brain-derived neurotrophic factor (BDNF), and their interaction in major depressive disorder's (MDD) etiology. This review includes (i) briefly defining cytokines, (ii) a discussion of theories for why they may affect brain function, (iii) cross-sectional associations between c...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212803523680

    authors: Lotrich F

    更新日期:2012-01-01 00:00:00

  • Anti-inflammatory heat shock protein 70 genes are positively associated with human survival.

    abstract::A positive relationship between stress tolerance and longevity has been observed in several model systems. That the same correlation is applicable in humans and that it may be open to experimental manipulation for extending human lifespan requires studies on association of stress genes with longevity. The involvement ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161210790883499

    authors: Singh R,Kølvraa S,Bross P,Christensen K,Bathum L,Gregersen N,Tan Q,Rattan SI

    更新日期:2010-01-01 00:00:00

  • Selective inhibitors of zinc-dependent histone deacetylases. Therapeutic targets relevant to cancer.

    abstract::Histone deacetylases (HDACs), which act on acetylated histones and/or other non-histone protein substrates, represent validated epigenetic targets for the treatment of cancer and other human diseases. The inhibition of HDAC activity was shown to induce cell cycle arrest, differentiation, apoptosis as well as a decreas...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666141110164604

    authors: Kollar J,Frecer V

    更新日期:2015-01-01 00:00:00

  • Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus.

    abstract::New biopharmaceutical molecules, potentially able to provide more personalized and effective treatments, are being identified through the advent of advanced synthetic biology strategies, sophisticated chemical synthesis approaches, and new analytical methods to assess biological potency. However, translation of many o...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151216151420

    authors: Munsell EV,Ross NL,Sullivan MO

    更新日期:2016-01-01 00:00:00

  • The pharmaceutical economics of child psychiatric drug treatment.

    abstract::The last decade, the number of health economic evaluations has increased substantially in the field of child psychiatry. The objective of the present paper is to offer an overview of economic evaluations of child psychiatric drug treatment. Major electronic databases, as well as abstract booklets from international cl...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210791959917

    authors: Schlander M

    更新日期:2010-01-01 00:00:00

  • Phosphodiesterase type 5 inhibitors: molecular pharmacology and interactions with other phosphodiesterases.

    abstract::Erectile function is determined by tight regulation of relaxation or contraction of corpus cavernosal smooth muscle, which is the result of a long and complex chain of molecular events. Control of erectile function resides in signaling pathways of the central and peripheral nervous system, as well as intracellular eve...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161205774913426

    authors: Seftel AD

    更新日期:2005-01-01 00:00:00

  • Pemafibrate Tends to have Better Efficacy in Treating Dyslipidemia than Fenofibrate.

    abstract:AIMS:To compare the efficacy of pemafibrate (PF) and fenofibrate (FF) in treating dyslipidemia. METHODS:A comprehensive search was performed on the public database to identify relevant randomized controlled trials (RCTs), which compared the effects of PF and FF treatment in lipid parameters among patients with dyslipi...

    journal_title:Current pharmaceutical design

    pub_type: meta分析

    doi:10.2174/1381612825666191126102943

    authors: Wang H,Li H,Zhou Y,Liu J,Wang F,Zhao Q

    更新日期:2019-01-01 00:00:00